AAAAAA
Results:
1-14
|
Results: 14
Authors:
Godschalk, RWL
Dallinga, JW
Wikman, H
Risch, A
Kleinjans, JCS
Bartsch, H
Van Schooten, FJ
Citation: Rwl. Godschalk et al., Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1, GSTT1, NAT1 and NAT2, PHARMACOGEN, 11(5), 2001, pp. 389-398
Authors:
Wikman, H
Thiel, S
Jager, B
Schmezer, P
Spiegelhalder, B
Edler, L
Dienemann, H
Kayser, K
Schulz, V
Drings, P
Bartsch, H
Risch, A
Citation: H. Wikman et al., Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility, PHARMACOGEN, 11(2), 2001, pp. 157-168
Authors:
Schmezer, P
Rajaee-Behbahani, N
Risch, A
Thiel, S
Rittgen, W
Drings, P
Dienemann, H
Kayser, KW
Schulz, V
Bartsch, H
Citation: P. Schmezer et al., Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes, MUTAGENESIS, 16(1), 2001, pp. 25-30
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer
Authors:
Rajaee-Behbahani, N
Schmezer, P
Risch, A
Rittgen, W
Kayser, KW
Dienemann, H
Schulz, V
Drings, P
Thiel, S
Bartsch, H
Citation: N. Rajaee-behbahani et al., Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer, INT J CANC, 95(2), 2001, pp. 86-91
Authors:
Bartsch, H
Nair, U
Risch, A
Rojas, M
Wikman, H
Alexandrov, K
Citation: H. Bartsch et al., Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers, CANC EPID B, 9(1), 2000, pp. 3-28
Authors:
von Zglinicki, T
Serra, V
Lorenz, M
Saretzki, G
Lenzen-Grossimlighaus, R
Gessner, R
Risch, A
Steinhagen-Thiessen, E
Citation: T. Von Zglinicki et al., Short telomeres in patients with vascular dementia: An indicator of low antioxidative capacity and a possible risk factor?, LAB INV, 80(11), 2000, pp. 1739-1747
Authors:
Wikman, H
Risch, A
Klimek, F
Schmezer, P
Spiegelhalder, B
Dienemann, H
Kayser, K
Schulz, V
Drings, P
Bartsch, H
Citation: H. Wikman et al., hOGG1 polymorphism and loss of heterozygosity (LOH): Significance for lungcancer susceptibility in a Caucasian population, INT J CANC, 88(6), 2000, pp. 932-937
Authors:
Mertzlufft, F
Koster, A
Hansen, R
Risch, A
Kuppe, H
Kubel, B
Crystal, GJ
Citation: F. Mertzlufft et al., Reliability of the heparin management test for monitoring high levels of unfractionated heparin - In vitro findings in volunteers versus in vivo findings during cardiopulmonary bypass, ANESTHESIOL, 92(6), 2000, pp. 1594-1602
Authors:
Risch, A
Dorscheid, E
Stein, G
Seyfert, UT
Grundmann, U
Citation: A. Risch et al., The effect of aprotinin and tranexamic acid on fibrinolysis and thrombin generation during cardiopulmonary bypass, ANAESTHESIS, 49(4), 2000, pp. 279-285
Authors:
Risch, A
Biedler, A
Mertzlufft, F
Citation: A. Risch et al., Preanalytical errors on the termination of arterial O-2-partial pressure and their impact on the AaDO(2), ANAESTHESIS, 49(1), 2000, pp. 29-33
Authors:
Thygesen, P
Risch, A
Stacey, M
Fakis, G
Takle, L
Knowles, M
Sim, E
Citation: P. Thygesen et al., Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer, PHARMACOGEN, 9(1), 1999, pp. 1-8
Authors:
Mongey, AB
Sim, E
Risch, A
Hess, E
Citation: Ab. Mongey et al., Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide, J RHEUMATOL, 26(8), 1999, pp. 1721-1726
Pre-analytic errors in the determination of arterial O-2-partial pressure under hyperoxic conditions
Authors:
Risch, A
Biedler, A
Mertzlufft, F
Citation: A. Risch et al., Pre-analytic errors in the determination of arterial O-2-partial pressure under hyperoxic conditions, ANAESTHESIS, 48(8), 1999, pp. 533-537
Authors:
Biedler, A
Risch, A
Mertzlufft, F
Citation: A. Biedler et al., Evaluation of lactate measurement in blood and plasma with biosensor technology: a comparison of methods, ANAESTHESIS, 47(12), 1998, pp. 968-974
Risultati:
1-14
|